NCT06747871View on ClinicalTrials.gov

Opioids, Low Nicotine Cigarettes, and Chronic Pain

NARecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 15, 2025

Primary Completion Date

July 30, 2027

Study Completion Date

July 30, 2027

Conditions
Chronic PainTobacco UseOpioid Substitution Treatment
Interventions
BEHAVIORAL

Very Low Nicotine Cigarettes (VLNC)

Spectrum NRC 102/103 (nonmenthol/ menthol) cigarettes, which have a nicotine content of approximately 0.4 mg/g tobacco.

BEHAVIORAL

Normal Nicotine Cigarettes (NNC)

Spectrum NRC 600/601 (nonmenthol/ menthol) cigarettes, which have a nicotine content of approximately 15.8 mg/g tobacco.

Trial Locations (1)

27705

RECRUITING

North Pavilion, Durham

Sponsors

Lead Sponsor

Duke University
All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

collaborator

National Institutes of Health (NIH)

NIH

lead

Duke University

OTHER